Provided by Tiger Fintech (Singapore) Pte. Ltd.

Charles River Laboratories

102.67
-3.3800-3.19%
Post-market: 102.680.0100+0.01%17:31 EDT
Volume:2.09M
Turnover:213.14M
Market Cap:5.04B
PE:513.35
High:103.91
Open:103.90
Low:99.80
Close:106.05
Loading ...

Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last?

Zacks
·
10 Apr

Charles River price target lowered to $145 from $160 at Barclays

TIPRANKS
·
10 Apr

Charles River Labs Is Maintained at Neutral by Mizuho

Dow Jones
·
09 Apr

Goldman Sachs Adjusts Charles River Laboratories International PT to $150 From $170, Maintains Neutral Rating

MT Newswires Live
·
09 Apr

Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

GlobeNewswire
·
08 Apr

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
08 Apr

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
04 Apr

Aldeyra down 75% after receiving CRL from FDA for reproxalap

TIPRANKS
·
03 Apr

Charles River Laboratories International Inc. Stock Falls 3.2%, Underperforms Competitors

Dow Jones
·
01 Apr

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

Reuters
·
01 Apr

Baird Adjusts Charles River Laboratories International Price Target to $155 From $173, Maintains Neutral Rating

MT Newswires Live
·
31 Mar

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate

Zacks
·
31 Mar

FDA Issues Complete Response Letter for Etripamil for PSVT

GlobeNewswire
·
28 Mar

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
27 Mar

Charles River Laboratories International Inc. Stock Sheds 3.4%, Underperforms Competitors

Dow Jones
·
26 Mar

Charles River, Valo Health Identify First Lupus Treatment Candidate Using Logica AI Platform

MT Newswires Live
·
25 Mar

Charles River and Valo Health Identify Potential Therapeutic for Lupus Using Logica

THOMSON REUTERS
·
25 Mar

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform

Business Wire
·
25 Mar

ABEO: Countdown to PDUFA Date of April 29, 2025…

Zacks Small Cap Research
·
24 Mar

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Mar